AWARDPURCHASE ORDEROther than small business
Purchase order HHSF223201610468PCHIRALIX B.V.
Overview
Award facts
- Net obligations
- $25K
- $25,000of $25K potential value
- Period of performance
- Aug 16, 2016 to Dec 23, 2016
- Ended
- Modifications
- 0
- Latest action Aug 16, 2016
- Contract type
- Purchase order
- PIID HHSF223201610468P
Description of requirement
PAENIBACILLUS PEPTIDE SYNTHESIS
Dates and value
- Award date
- Signed on Aug 16, 2016
- Potential end of performance
- Dec 22, 2016
- Current value
- $25,000Base and exercised options
- Potential value (if all options are exercised)
- $25,000
Obligations by fiscal year of action
- FY2016: $25,000
Total across 1 fiscal year: $25,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 16, 2016. View on USAspending · Recipient on SAM.gov
Recipient
NameCHIRALIX B.V.
LocationNIJMEGEN, NLD
UEIGEC4Z17U4NU4
Business sizeOther than small businessSize at award, per the contracting officer
Parent companyCHIRALIX B.V.
Business types and certifications
Foreign-ownedFor-profit organization
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
Place of performance
- Place of performance
- Netherlands
Classification and competition
Classification
- Product or service (PSC)
- 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (product)
Competition
- Extent competed
- Not competedC
- Reason not competed
- Only one source - otherONE
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Peptide synthesis
- Commercial procedures
- Commercial itemA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 16, 2016Base obligation at award: $25,000
- Latest action
- Aug 16, 2016 — Base awardModification 0; obligation change +$25,000
- Actions by type
- Base award1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $25,000
- Latest action: change in base and all options
- $25,000
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business not incorporated in the U.S.D
- Country of product or service origin
- NetherlandsNLD
- Place of manufacture
- Mfg outside U.S. - use outside the united statesE
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 1
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401